Californians were far less likely to die from covid in the first seven months of 2022 than during the first two years of the pandemic. Still, the virus remained among the state’s leading causes of death in July, outpacing diabetes, accidental death, and a host of debilitating diseases. We break down who’s at risk.
Two studies published this year provide evidence that older adults’ cognitive health may benefit if air quality is improved.
In this episode, Julie Rovner, chief Washington correspondent for KHN, guides listeners through decades of dealings between Congress and Big Pharma.
With prices of necessities rising dramatically, many older Americans are having trouble making ends meet. They often don’t know that help is available from a variety of programs, and some sources of financial assistance are underused.
Three women explain how life’s surprises can catapult their efforts to carefully manage limited budgets and lead to financial distress.
The omicron variant has proved adept at finding hosts, often by reinfecting people who recovered from earlier bouts of covid. But whether omicron triggers long covid as often and severe as previous variants is a matter of heated study.
Inflation hasn’t hit Americans like this in decades. And families living with chronic diseases have little choice but to pay more for the medicine, supplies, and food they need to stay healthy.
In pursuit of unpaid bills, nursing homes across Rochester, New York, have been suing relatives and friends of their residents. This CBS News report, done in partnership with a KHN-NPR investigation, takes a look at the practice and tells the stories of some of the people affected.
Under the Medicare drug negotiations provisions in the reconciliation bill, the federal government would see its outlays reduced by about $300 billion. That reduction wouldn’t result from cuts in benefits. Instead, Medicare would be empowered to leverage its market power to pay lower prices for certain drugs.
People whose brains have been injured by concussions, traumatic accidents, strokes, or neurodegenerative conditions such as Parkinson’s disease can benefit from targeted therapy. Experts also employ therapies for long-covid patients with memory and language problems.
